Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.


Mentoring Oncologists in the Era of Social Distancing

October 22nd 2020

Mentoring is critically important to the development of young academic hematology/oncology trainees.

Gandara Evaluates Opportunities for Virtual Education, Expansion, and Engagement Amid COVID-19

October 19th 2020

In our exclusive interview, David R. Gandara, MD highlights the benefits and challenges of delivering patient care virtually and its reception among patients, discusses the sustainability of virtual CME platforms and forecasts what the “new normal” of oncology education may look like as a result of the pandemic.

Complex Clinical Trial Issues Require an Ethical Balancing Act

October 13th 2020

The fundamental objectivity of major scientifically oriented public health agencies has been called into question, while the issue of what constitutes sufficient evidence for a therapeutic strategy to be considered “standard” is also being challenged.

Leading Biochemist Charles Brenner, PhD, Joins City of Hope as Chair of First Department Focused on Diabetes and Cancer Metabolism

August 27th 2020

Charles Brenner, PhD, joins City of Hope as chair of first department focused on diabetes and cancer metabolism.

Drug Repositories Aim to Solve Access Issues

August 18th 2020

Financial issues are among the top concerns burdening patients with cancer.

Steven Grossman, MD, PhD, Named Cancer Physician in Chief of USC Norris Comprehensive Cancer Center

August 4th 2020

Renowned oncologist and cancer researcher will begin inaugural position in September.

ASCO and ACCC Collaborate to Boost Racial/Ethnic Representation in Cancer Treatment Trials

July 27th 2020

A new collaboration between the American Society of Clinical Oncology and the Association of Community Cancer Centers aims to encourage the enrollment of more racially and ethnically diverse patients with cancer onto clinical trials.

Oral Oncolytics Will Require Health Care System to Adapt

July 21st 2020

Judging from the drug pipeline, the future of oncology is oral chemotherapy.

Daniel Osman, Founder of Miami Breast Cancer Conference, Dies

July 18th 2020

Daniel A. Osman, MD, a South Florida surgeon who founded the Miami Breast Cancer Conference® and helped shepherd its growth into a premier medical meeting, died peacefully in Weston, Florida, on July 15 at the age of 98.

FDA Launches Pilot Website Housing Publicly Available PRO Data From Cancer Trials

June 24th 2020

The FDA has launched a new initiative called Project Patient Voice, which is a website that will serve as a source of publicly available information regarding patient-reported symptoms from cancer trials examining marketed treatments.

Pharmacy Operations Can Enhance Reimbursement Picture for Oncology Drugs

June 6th 2020

Pharmacists can play a role in the drug reimbursement process for oncology products, which are among the most expensive of all pharmaceuticals.

Pandemic Poses a Crucial Moment for Science and the Public Trust

June 2nd 2020

At this moment, we should consider what it will take for the scientific community as a collective entity to self-regulate far more forcefully so that the actions of a limited number of its members do not squander the well-deserved awakening of public trust in the entire scientific enterprise.

Relapsed/Refractory HER2+ mBC: Future Treatment Landscape

May 18th 2020

HER2CLIMB: Sequencing in Metastatic Breast Cancer

May 18th 2020

Personal Experience With the HER2CLIMB Regimen in mBC

May 18th 2020

HER2+ mBC: Safety and Tolerability in HER2CLIMB

May 18th 2020

HER2CLIMB: Implications for Brain Metastases in HER2+ mBC

May 18th 2020

Exciting Results From HER2CLIMB in HER2+ mBC

May 18th 2020

Relapsed/Refractory HER2+ mBC: Evolving Treatment Landscape

May 18th 2020

Cancer Mortality Rate Declined More Steeply in States That Expanded Medicaid Under the Affordable Care Act

May 14th 2020

The cancer mortality rate declined more in states that expanded Medicaid coverage than those that didn’t following the passage of the Affordable Care Act of 2010, a study found.